首页> 外文期刊>Spectrochimica acta, Part A. Molecular and biomolecular spectroscopy >Structural investigation of a 2:1 co-crystal between diflunisal and isonicotinamide based on terahertz and Raman spectroscopy
【24h】

Structural investigation of a 2:1 co-crystal between diflunisal and isonicotinamide based on terahertz and Raman spectroscopy

机译:基于太赫兹和拉曼光谱法的二韵和异滴鼻酰胺的2:1共晶的结构研究

获取原文
获取原文并翻译 | 示例
           

摘要

In order to characterize molecular structure changes of drugs upon co-crystallization by means of spectroscopic techniques, vibrational spectra of solid-state diflunisal (DIF), isonicotinamide (ISO) and their 2:1 co-crystal have been investigated by using terahertz time-domain spectroscopy (THz-TDS) and Raman spectroscopy. A 2:1 DIF-ISO co-crystal between DIF and ISO has been synthesized by slow solution crystallization from ethanol. The experimental THz spectroscopy shows that the co-crystal has a few significantly different absorption peaks compared with raw parentmaterials within the frequency region from 0.2 to 1.6 THz. Likewise, some differences of vibrational spectra between the co-crystal and starting compounds could also be characterized by Raman spectral results. Density functional theory (DFT) was used to simulate optimized structures and vibrational modes of two kind of possible co-crystal theoretical forms (form I and II) between DIF and ISO. Theoretical co-crystal form I is shown with 2: 1 theoretical binary-adduct formed by carboxylic acid-amide and carboxylic acid-pyridine under intermolecular hydrogen bonding. Theoretical co-crystal form II has a similar structure as form I, meanwhile the only difference is that O63 atom simultaneously forms hydrogen bond with H33 and H64. Also the hydroxyl -OH and carboxyl group -COOH establish molecular heterocycle under intra-molecular hydrogen bonds in both forms. The theoretical results show that both THz and Raman spectra of co-crystal form II between DIF and ISO is more consistent with the experimental observations than those of co-crystal form I. These results provide us with a wealth of information and unique method for characterizing the composition of co-crystal structures and also intermolecular hydrogen bonding interactions shown within pharmaceutical co-crystallization at the molecular level. (C) 2019 Elsevier B.V. All rights reserved.
机译:为了通过光谱技术表征药物在共结晶时的分子结构变化,通过使用太赫兹时间研究了固态Diflunisal(DIF),异烟酰胺(ISO)的振动光谱和其2:1的共晶 - 畴光谱(THZ-TDS)和拉曼光谱。通过乙醇的慢溶液结晶合成DIF和ISO之间的2:1在DIF和ISO之间的差异。实验性THz光谱表明,与频率区域内的原始母体材料相比,共晶体具有少量不同的吸收峰。同样地,共晶和起始化合物之间的振动光谱的一些差异也可以通过拉曼光谱结果表征。密度泛函理论(DFT)用于模拟DIF和ISO之间的两种可能的共晶理论形式(形式I和II)的优化结构和振动模式。理论共晶形式I显示为2:1在分子间氢键下由羧酸 - 酰胺和羧酸 - 吡啶形成的理论二元加合物。理论共晶形式II具有与形式I类似的结构,同时唯一的差异是O63原子同时形成氢键与H33和H64。此外,羟基-OH和羧基-OOH -COOH在两种形式的分子内氢键下建立分子杂环。理论结果表明,DIF和ISO之间的共晶形式II的THz和拉曼谱与实验观察更一致,而不是共晶形式I.这些结果为我们提供了丰富的信息和独特的表征方法共晶体结构的组成以及分子水平的药物共结晶中的分子间氢键相互作用。 (c)2019 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号